San Diego-based Viking Therapeutics marked alone as a serious competitor inside the weight loss drug industry in February following revealing promising knowledge from the mid-phase trial of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when provided as being a weekly injection As well as in March t